THE POPULAR NOOTROPIC IS FINALLY BACK
Remember our first phenylpiracetam-based product, Phenotropil? It used to be really popular, but you may know it’s no longer sold. The thing is that the patent holder stopped working with the previous producer and started setting up their own production. That’s why for some time we were selling an expensive Latvian analog called Entrop. Now, the original medication is finally back! Meet it again under the new brand name: NANOTROPIL®. It’s produced by Valenta Pharm in Russia, so now you can get it as much as you need: no limitations!
WHAT IS NANOTROPIL?
The chemical compound of NANOTROPIL® has the following effects:
- A moderate psychostimulating effect combined with anxiolytic properties i.e. mood-lifting and anxiety reduction
- Adaptogenic effects, i.e. combating mental and physical fatigue under stress.
- Increased resistance of brain tissue to hypoxia and toxins.
- Combating mild depressions by increasing serotonin, dopamine, and noradrenaline in the brain.
- Better visual acuity and range.
- Increased tolerance to cold.
- Mild immunostimulating properties.
NANOTROPIL® can be officially used both for healthy individuals experiencing various kinds of stress and also for those who have the following indications:
- Extreme work conditions e.g. excessive intellectual or physical requirements
- As a study aid for concentration improvement.
- Mild and moderate depressions
- Chronic fatigue syndrome
- Cerebrovascular diseases
- Alcohol hangover symptoms
- Other conditions characterized by reduced intellectual productivity
Although NANOTROPIL® is a non-habit-forming drug it is different from other Racetams in that it might cause a mild receptor down-regulation in certain individuals when taken for long periods of time.
The preparation is presented on the same page as Entrop because they are based on the same active substance: just choose your option!
MORE ABOUT PHENYLPIRACETAM
The active substance is the same well-known Phenylpiracetam. Developed by a cosmic branch of the pharmaceutical industry in Russia in the 80th, Phenylpiracetam was another nootropic included in the cosmonaut’s kit. As a famous astronaut Alexander Serebrov said, who used phenylpiracetam during his 197-day flight, the preparation worked for him as a “normalizer”: it decreased impulsivity and irritability – conditions that will always happen during a long-term stay in space. Phenylpiracetam was developed because the state needed it at the time when there was no totally safe substitute with the same effects. This pharmaceutical was also tested a countless number of times on animals and was used on more than 500 patients across the country before becoming available to the general population.
The creator of Phenylpiracetam, Valentina Ahapkina, wanted to synthesize a pharmaceutical that is capable of unleashing the body energy without draining it. Phenylpiracetam appeared to be her closest attempt.
It has a direct activating effect on the integrative activity of the brain, promotes memory consolidation, improves concentration and mental activity, facilitates the learning process, increases the resistance of brain tissue to hypoxia and toxic effects, exhibits anticonvulsant and anxiolytic activity, regulates the processes of activation and inhibition of the CNS, and improves mood.